Improving scientific practice in sports‐associated drug testing

Improving scientific practice in sports‐associated drug testing / Jon Nissen‐Meyer, Tore Skotland, Bjarne Østerud, Erik Boye / FEBS Journal 286 (2019) 14 (July); p.2664-2669).
- PMID: 31095893.
- DOI: 10.1111/febs.14920

Correction added on 30 May 2019, after first online publication: the original publication incorrectly included a superfluous paragraph from an earlier version of the manuscript in the section “Lack of accountability and transparency”.


Antidoping work is heavily based on scientific analyses of biological material, such as urine and blood. Because of the high stakes both for sports and for the athletes involved it is important that analyses are performed and interpreted in agreement with established scientific standards and professional norms. This is not always the case, as we document here. It is our experience that the antidoping movement does not appear willing to consider that errors can occur and should be corrected. The consequences of the lack of transparency and responsibility are carried by unlucky athletes. Scientific, ethical and legal considerations urge the antidoping movement to reform some of their rules and regulations and to include the possibility that the World Anti-Doping Agency position could, in some cases, be incorrect.

Original document


Case report
16 May 2019
Boye, Erik
Nissen-Meyer, Jon
Skotland, Tore
Østerud, Bjarne
Adverse Analytical Finding / presence
Legal Terms
Anti-Doping policy
Other organisations
Oslo universitetssykehus HF - Oslo University Hospital
Universitetet i Oslo - University of Oslo
Universitetet i Tromsø – Norges arktiske universitet - University of Tromsø - The Arctic University of Norway
World Anti-Doping Agency (WADA)
Cologne, Germany: Institute of Biochemistry - German Sport University Cologne
Kreischa, Germany: Institute of Doping Analysis and Sports Biochemistry (IDAS)-Dresden
Analytical aspects
False Positive
Reliability of the testing method / testing result
Doping classes
S2. Peptide Hormones, Growth Factors
Erythropoietin (EPO)
Document category
Scientific article
Document type
Pdf file
Date generated
1 August 2019
Date of last modification
9 August 2019
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period